<code id='DEB4B27AB5'></code><style id='DEB4B27AB5'></style>
    • <acronym id='DEB4B27AB5'></acronym>
      <center id='DEB4B27AB5'><center id='DEB4B27AB5'><tfoot id='DEB4B27AB5'></tfoot></center><abbr id='DEB4B27AB5'><dir id='DEB4B27AB5'><tfoot id='DEB4B27AB5'></tfoot><noframes id='DEB4B27AB5'>

    • <optgroup id='DEB4B27AB5'><strike id='DEB4B27AB5'><sup id='DEB4B27AB5'></sup></strike><code id='DEB4B27AB5'></code></optgroup>
        1. <b id='DEB4B27AB5'><label id='DEB4B27AB5'><select id='DEB4B27AB5'><dt id='DEB4B27AB5'><span id='DEB4B27AB5'></span></dt></select></label></b><u id='DEB4B27AB5'></u>
          <i id='DEB4B27AB5'><strike id='DEB4B27AB5'><tt id='DEB4B27AB5'><pre id='DEB4B27AB5'></pre></tt></strike></i>

          knowledge

          knowledge

          author:hotspot    Page View:11
          Richard Neal(D-MA), Rep. Frank Pallone (D-NJ),Rep. John Yarmuth (D-KY), Rep. Bobby Scott (D-VA) and House Minority Leader Nancy Pelosi (D-CA) attend the weekly press conference in the Capitol building on July 20, 2017 in Washington, DC. They spoke to the media about the efforts to reform the health care bill. -- health policy coverage from STAT
          Reps. Richard Neal (D-Mass.), Rep. Frank Pallone (D-N.J.), and Rep. John Yarmuth (D-Ky.) Joe Raedle/Getty Images

          WASHINGTON — It’s drug pricing déjà vu: Just as they did in 2019, House Democrats are pushing a bill that would allow Medicare to negotiate dozens of drug prices a year, offer those prices to all insurers, and crack down on price hikes.

          Unlike then, Democrats have a starting place: the new bill represents an expansion of the major drug pricing legislation the party passed last year. But the first round of drug price negotiations hasn’t even started yet, and the law is under attack from the pharmaceutical industry in court.

          advertisement

          The Democratic leaders of three key House committees put forth the proposal Wednesday.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more
          Dewpoint Therapeutics lays off staff after losing partnerships
          Dewpoint Therapeutics lays off staff after losing partnerships

          AdobeDewpointTherapeutics,thebuzzieststartuptryingtotackleanewfieldofbiologycalledbiomolecularconden

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Independent physicians launch a new lobbying group

          PaulBerggreen,agastroenterologistatArizonaDigestiveHealthwhoformedanewlobbyinggroupforindependentphy